Mass spectrometry-based phosphoproteomics of tumor needle biopsies from patients (pts) with advanced solid tumors during treatment with protein kinase inhibitors.

Mariette Labots,Robin Beekhof,Jaco C. Knol,Maarten Neerincx,Richard R. de Haas,Henk L. Dekker,Thang V. Pham,Sander R. Piersma,Evan Henneberry,Johannes C. van der Mijn,Maria Rovithi,Donald L. van der Peet,Martijn R. Meijerink,Nicole C.T. van Grieken,Connie R. Jimenez,Henk M.W. Verheul

Mass spectrometry-based phosphoproteomics of tumor needle biopsies from patients (pts) with advanced solid tumors during treatment with protein kinase inhibitors.

2016

Mariette Labots
Robin Beekhof
Jaco C. Knol
Maarten Neerincx
Richard R. de Haas
Henk L. Dekker
Thang V. Pham
Sander R. Piersma
Evan Henneberry
Johannes C. van der Mijn
Maria Rovithi
Donald L. van der Peet
Martijn R. Meijerink
Nicole C.T. van Grieken
Connie R. Jimenez
Henk M.W. Verheul

11609Background: Mass spectrometry-based phosphoproteomics of tumor tissue lysates provides a potential personalized medicine approach based on its global information on aberrantly activated signal...

Keywords:

Protein kinase A
Phosphoproteomics
Pathology
Mass spectrometry
Cancer research
Medicine
Personalized medicine
tumor tissue
global information

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations